PFx Closure System in Subjects With Cryptogenic Stroke, TIA, Migraine or Decompression Illness "Paradigm IV"

Suspended

Phase N/A Results N/A

Summary of Purpose

The primary object of this study is to demonstrate the continued safety and performance of the PFx Closure System when utilized for patients with PFOs suffering from cryptogenic stroke, transient ischemic attack, migraine or decompression illness.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 December 2007.

1 Aug 2007 12 Sep 2007 Unavailable 1 Dec 2007 1 Dec 2007 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions See All

Sponsors

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

Not available